扩张型心肌病患者的遗传风险与心律失常表型
本研究纳入487例扩张型心肌病患者,采用二代测序将疾病基因分为功能基因组,评估基因变异携带状态与复合结局的关系。结果显示,桥粒蛋白和LMNA基因变异携带者发生心源性猝死/室性心动过速/心室颤动的风险最高,且独立于左心室射血分数。
要点
- 桥粒蛋白和LMNA基因变异携带者的SCD/VT/VF风险最高。
- 基因变异携带状态与全因死亡率无关。
- SCD/VT/VF风险独立于左心室射血分数。
核心结论
- 桥粒蛋白和LMNA基因变异可识别SCD及致命性室性心律失常风险最高的DCM患者亚组,且独立于左心室射血分数。
研究设计与样本
- 研究分析了487例DCM患者,通过二代测序将疾病基因分为功能基因组,评估复合结局指标。
主要发现
- 178例(37%)患者携带183个致病/可能致病变异。
- 变异携带者与未携带者的全因死亡率无差异(p=0.99)。
- 携带者SCD/VT/VF有更差趋势(p=0.062),DHF/HTx/VAD也有更差趋势(p=0.061)。
- 桥粒蛋白和LMNA变异携带者的SCD/VT/VF发生率最高,且独立于左心室射血分数。
关键数值与推荐
- 致病/可能致病变异分布:Titin 54例(11%),LMNA 19例(4%),结构细胞骨架-Z盘基因24例(5%),桥粒蛋白基因16例(3.5%),肌节基因46例(9.5%),离子通道基因8例(1.6%),其他基因11例(2.5%)。
临床怎么用
- 对DCM患者进行基因检测,重点关注桥粒蛋白和LMNA基因变异,以识别SCD高危患者,考虑ICD植入决策时不应仅依赖左心室射血分数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genotype-phenotype correlations in dilated cardiomyopathy (DCM) and, in particular, the effects of gene variants on clinical outcomes remain poorly understood. OBJECTIVES: The purpose of this study was to investigate the prognostic role of genetic variant carrier status in a large cohort of DCM patients. METHODS: A total of 487 DCM patients were analyzed by next-generation sequencing and categorized the disease genes into functional gene groups. The following composite outcome measures were assessed: 1) all-cause mortality; 2) heart failure-related death, heart transplantation, or destination left ventricular assist device implantation (DHF/HTx/VAD); and 3) sudden cardiac death/sustained ventricular tachycardia/ventricular fibrillation (SCD/VT/VF). RESULTS: A total of 183 pathogenic/likely pathogenic variants were found in 178 patients (37%): 54 (11%) Titin; 19 (4%) Lamin A/C (LMNA); 24 (5%) structural cytoskeleton-Z disk genes; 16 (3.5%) desmosomal genes; 46 (9.5%) sarcomeric genes; 8 (1.6%) ion channel genes; and 11 (2.5%) other genes. All-cause mortality was no different between variant carriers and noncarriers (p = 0.99). A trend toward worse SCD/VT/VF (p = 0.062) and DHF/HTx/VAD (p = 0.061) was found in carriers. Carriers of desmosomal and LMNA variants experienced the highest rate of SCD/VT/VF, which was independent of the left ventricular ejection fraction. CONCLUSIONS: Desmosomal and LMNA gene variants identify the subset of DCM patients who are at greatest risk for SCD and life-threatening ventricular arrhythmias, regardless of the left ventricular ejection fraction.
引用
- Gigli M, Merlo M, Graw SL, et al. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol. 2019. PMID: 31514951. doi:10.1016/j.jacc.2019.06.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。